NuRaX Blog

Focal neuropathic pain — pain arising from injury, compression, or dysfunction of specific peripheral nerves — is one of the most challenging pain syndromes to manage effectively. Unlike generalized pain conditions, focal neuropathic pain is often highly localized, following the anatomical distribution of a single nerve or nerve branch, and it frequently fails to respond adequately to systemic analgesic medications. Patients with conditions such as occipital neuralgia, post-traumatic peripheral nerve injury, or chronic shoulder and knee pain of neural origin often cycle through multiple treatment modalities without achieving lasting relief.

Peripheral Nerve Stimulation (PNS) represents a powerful and increasingly well-validated therapeutic option for this patient population. By delivering targeted electrical impulses directly to the affected peripheral nerve, PNS modulates pain signaling at the source — bypassing the limitations of systemic drug therapy and achieving focal, precise relief with a minimally invasive approach. At NuRaX Care and Research Center, PNS is a core component of our neuromodulation toolkit for complex regional and peripheral pain conditions.

Understanding the PNS Mechanism

The fundamental principle underlying PNS parallels that of spinal cord stimulation: electrical stimulation of a sensory nerve activates large-diameter Aβ fibers that inhibit pain signal transmission carried by smaller C and Aδ fibers. In PNS, however, this inhibitory effect is applied at the level of the peripheral nerve itself, upstream of the spinal cord, offering several important therapeutic advantages.

Because stimulation targets the specific nerve responsible for the patient's pain, PNS can achieve precise anatomical coverage that is often impossible with spinal cord-level stimulation. The technique also avoids the anatomical constraints of paraspinal electrode placement and can reach nerves in the head, face, limbs, and trunk that are inaccessible via epidural approaches. Advanced ultra-low-frequency PNS waveforms have demonstrated efficacy in reducing central sensitization — the amplification of pain signals in the brain — in addition to their peripheral effects, broadening the mechanism of benefit beyond simple afferent inhibition.

Conditions Treated with Peripheral Nerve Stimulation

PNS has demonstrated clinical efficacy across a diverse range of focal pain conditions, with emerging evidence for several new indications:

• Occipital Neuralgia and Chronic Migraine: Occipital nerve stimulation is one of the most established PNS applications, providing sustained reduction in headache frequency and severity for patients with medically refractory occipital neuralgia and chronic migraine. Electrode leads are placed subcutaneously overlying the greater and lesser occipital nerves at the back of the skull.
• Shoulder Pain: Suprascapular nerve stimulation has emerged as an effective option for chronic shoulder pain — including pain from rotator cuff pathology, glenohumeral arthritis, and post-surgical pain — particularly in patients who are not candidates for further orthopedic intervention.
• Post-amputation Pain and Phantom Limb Pain: PNS of peripheral nerve remnants at the amputation site or targeted to the residual nerve endings has demonstrated meaningful reductions in phantom limb pain, a notoriously difficult condition to treat.
• Knee Osteoarthritis Pain: Percutaneous PNS targeting the genicular nerves around the knee joint provides durable pain relief for patients with osteoarthritis, reducing the need for opioid medications and delaying or avoiding the need for joint replacement surgery.
• Post-traumatic Nerve Pain: Injuries to peripheral nerves in the extremities, face, or trunk can lead to chronic pain that persists long after tissue healing. PNS placed adjacent to the injured nerve can interrupt aberrant pain signal transmission and restore normal nerve function.
• Inguinal and Abdominal Wall Pain: Ilioinguinal, iliohypogastric, and genitofemoral nerve stimulation effectively treats chronic groin and abdominal wall pain from surgical mesh, hernia repair, or nerve injury.

The PNS Implantation Procedure

Modern PNS systems have evolved dramatically from the open surgical procedures of earlier decades. The majority of PNS implantations today are performed percutaneously — without open surgery — using needle-based delivery systems that place flexible, ultra-thin electrode leads adjacent to the target nerve under ultrasound guidance. This minimally invasive approach dramatically reduces procedural risk, eliminates the need for general anesthesia in most cases, and significantly shortens recovery time.

Like spinal cord stimulation, PNS typically includes a trial phase in which temporary leads are placed and connected to an external stimulator for a period of ten to sixty days. This extended trial allows a thorough assessment of therapeutic benefit across a wide range of daily activities and pain-provoking situations. Newer wireless PNS systems do not require a percutaneous lead extension to an external generator; instead, a small implanted receiver receives energy from an external patch worn over the skin, completely eliminating infection risk at a lead exit site.

If the trial demonstrates sufficient benefit — typically defined as at least 50% pain reduction with functional improvement — permanent implantation is performed. Some devices are designed as fully implantable permanent systems from the outset, with wireless charging eliminating the need for battery replacement surgery.

The ability to place PNS electrodes percutaneously under ultrasound guidance has transformed what was once a complex surgical procedure into a minimally invasive outpatient intervention — dramatically expanding access to this effective therapy.

Clinical Evidence and Outcomes

The clinical evidence base for PNS has expanded substantially in recent years, with several landmark randomized controlled trials establishing its efficacy across multiple indications:

• Occipital neuralgia and headache: Studies report 50–70% of patients achieving greater than 50% reduction in headache frequency and pain intensity, with sustained benefit at two-year follow-up.
• Shoulder pain: Randomized trials demonstrate average pain reductions of 70–80% at three months with PNS, compared to minimal benefit from sham stimulation controls.
• Knee osteoarthritis: Trials report 50% or greater pain reduction in approximately 65–75% of treated patients at 6 months, with parallel improvements in physical function and activity levels.
• Post-amputation pain: PNS achieves meaningful phantom limb pain reduction in approximately 60–70% of patients, with some individuals reporting near-complete resolution of symptoms that had persisted for years.

PNS at NuRaX: Precision, Expertise, and Innovation

At NuRaX Care and Research Center, our pain specialists offer the full range of peripheral nerve stimulation technologies, including both conventional implantable systems and next-generation wireless platforms. Our use of high-resolution ultrasound guidance for lead placement maximizes both safety and precision, ensuring optimal electrode positioning relative to the target nerve anatomy.

We take an individualized approach to every PNS candidate, conducting thorough diagnostic nerve blocks to confirm the pain-generating nerve before proceeding to stimulation. Our multidisciplinary team — encompassing pain specialists, neurologists, and physiotherapists — works collaboratively to optimize outcomes beyond device placement, incorporating rehabilitation strategies that support long-term functional recovery alongside pain relief.

If you are living with focal nerve pain that has not responded to conventional treatments, peripheral nerve stimulation may offer a precisely targeted, minimally invasive path to meaningful and lasting relief. Contact NuRaX today to arrange a comprehensive evaluation.